What the Mounjaro pen looks like after all 4 doses are used

What the official guidance says about how the KwikPen is designed

The Mounjaro KwikPen is a pre-filled, single-patient-use device. According to the Summary of Product Characteristics published on the electronic Medicines Compendium, each pen delivers four subcutaneous injections at the labelled strength before it is exhausted. Eli Lilly designed the pen so that two things change visibly as you work through it: the plunger rod inside the barrel moves progressively downward, and the dose counter window (a small numbered display on the body of the pen) decrements after each completed injection.

Before any dose, the counter reads 4. After your first injection it reads 3, after the second it reads 2, after the third it reads 1, and after the fourth it reads 0. That final zero is your confirmation the pen is done. If the plunger appears fully depressed and the window shows 0, you have had all four doses and no usable medicine remains. This is by design: the pen cannot be accidentally over-dosed or drawn past its intended four-injection limit.

For detailed visual guidance specific to your pen's strength and batch, the Mounjaro SmPC on the eMC and your printed Patient Information Leaflet contain step-by-step illustrations of the device in each state. These are the authoritative references; they supersede anything a general webpage can describe.

What the pen looks like at each stage, dose 1 through dose 4

After dose 1, the barrel still looks largely full of liquid. The plunger has moved only a quarter of its total travel, which can be hard to see through the opaque or coloured casing depending on your pen's strength. The counter window is your more reliable guide: it now shows 3.

By dose 2 the plunger has reached roughly the halfway point of its travel, and our guide to the pen after 2 doses explains what you should see at this point and what is normal. Some patients notice the barrel feels slightly lighter. The window reads 2. A question our prescribers hear most weeks at this stage is whether a pen that still looks half-full might have a fault, in almost every case it does not; the liquid is denser than it looks, and a quarter of the pen's volume delivers one full dose.

After dose 3 the counter reads 1 and the plunger is three-quarters of the way down. There is exactly one week's medicine remaining. This is the time to confirm your next pen is on its way. If you are thinking ahead to your next strength, reading about what to expect at 5 mg or checking the cost of each monthly pen in the UK can help you plan.

After dose 4 the counter reads 0 and the plunger has reached its lowest position, and our guide to the pen after 4 doses walks through exactly what you will see and confirms the pen is empty. Do not attempt another injection; do not try to draw medicine out with a syringe. The pen should be treated as clinical waste: cap the needle, place it in a sharps bin, and arrange collection through your local council or pharmacy take-back scheme.

Storage and appearance between doses, things worth knowing

Between injections you keep the pen in a refrigerator at 2–8 °C. A correctly stored pen at any stage should contain a clear, colourless to slightly yellow liquid with no visible particles or cloudiness. If the liquid looks discoloured, cloudy or contains floating material at any point (whether after dose 1 or dose 3) do not inject it. Contact your pharmacy or prescriber for advice. The NHS tirzepatide medicines page notes that Mounjaro should not be used if the solution has changed appearance, and the SmPC gives the precise room-temperature window for the pen when you take it out before an injection; always check the leaflet for the exact figure rather than relying on a third-party source.

One practical note: the pen in your fridge after three doses looks almost indistinguishable from a new pen at a glance. Keeping pens in their original labelled cartons and writing the date of your first injection on the box removes any ambiguity. If you are unsure how many doses you have taken from a particular pen, the counter window is definitive. For more on what to expect specifically after finishing a pen's first injection, the guide to the pen after one dose explains the early visual and physical changes in detail.

Questions about changing your injection site, what to do if a dose is missed, or when to move to your next strength all sit with your prescriber, not this page. The licensed dosing schedule for tirzepatide is described in full on the Mounjaro overview. If your treatment is with nume, our prescribers are available seven days a week through our aftercare contact to help with exactly these questions.

Disposing of the finished pen safely

A Mounjaro pen at zero doses still contains a needle and residual traces of medicine. UK waste rules class it as sharps clinical waste. It must not go into your recycling bin or general household rubbish. Place it in an approved sharps container (the kind with a yellow lid) seal it when three-quarters full, and return it via your local council's sharps collection service or a participating pharmacy. Many areas offer free collections; your local council website will list the options. The nume FAQs page covers disposal questions specific to patients on our service. Proper disposal protects refuse collectors and anyone else who might handle the bag, it is a straightforward step that matters.

If you are considering starting Mounjaro or have questions about whether it is the right treatment for you, our free consultation connects you with a GPhC-registered Independent Prescriber the same day, a real clinician who reviews your answers personally, not an automated decision tool.